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Abstract
In mammals, observations of rapid shifts in mitochondrial DNA (mtDNA) variants between generations have led to the
creation of the bottleneck theory for the transmission of mtDNA. The bottleneck could be attributed to a marked decline of
mtDNA content in germ cells giving rise to the next generation, to a small effective number of mtDNA segregation units
resulting from homoplasmic nucleoids rather than the single mtDNA molecule serving as the units of segregation, or to the
selective transmission of a subgroup of the mtDNA population to the progeny. We have previously determined mtDNA
copy number in single germ cells and shown that the bottleneck occurs without the reduction in germline mtDNA content.
Recently one study suggested that the bottleneck is driven by a remarkable decline of mtDNA copies in early primordial
germ cells (PGCs), while another study reported that the mtDNA genetic bottleneck results from replication of a
subpopulation of the mtDNA genome during postnatal oocyte maturation and not during embryonic oogenesis, despite a
detected a reduction in mtDNA content in early PGCs. To clarify these contradictory results, we examined the mtDNA copy
number in PGCs isolated from transgenic mice expressing fluorescent proteins specifically in PGCs as in the aforementioned
two other studies. We provide clear evidence to confirm that no remarkable reduction in mtDNA content occurs in PGCs
and reinforce that the bottleneck is generated without reduction of mtDNA content in germ cells.
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Introduction
Mammalian mitochondrial genome shows a 5 to 10 times greater
mutation rate than the nuclear genome [1,2]. This elevated
mutation rate coupled with clonal maternal transmission leads to
the high mtDNA polymorphism in populations. However, despite
the prevalence of genetic variance within a species, most individuals
possess only a single mtDNA variant. Pedigree analyses of
heteroplasmic individuals in cattle, mice and humans revealed that
mtDNA genotypes shift rapidly among offspring and return to
homoplasmy in some progeny within a few generations [3–8],
suggesting that a mtDNA bottleneck accounts for the rapid
segregation. Early studies have proposed that the bottleneck occurs
in embryonic development in consequence of a drastic reduction of
mtDNA content in PGCs [9,10]. In mice, the size of the bottleneck
is estimated as to be ,200 mtDNA segregation units [11].
To test these hypotheses, three independent research groups
have attempted to quantify mtDNA copy number in single germ
cells at different developmental stages in mice. Cao et al. [12]
made the first direct measurements of mtDNA copy number in
single PGCs (identified by endogenous alkaline phosphatase (ALP)
activity) in wild-type mice using quantitative real-time PCR (qrt-
PCR) and found that PGCs contained consistent amounts of
mtDNA with a mean of ,1350–3600 copies per cell between 7.5
days post coitum (dpc) and 13.5 dpc, indicating that the bottleneck
occurs without a marked reduction of mtDNA copies in PGCs.
Recently using Stella-GFP transgenic mice to isolate PGCs, a study
determined a mean of ,450 mtDNA copies per PGC at 7.5 dpc
(median ,200) and a mean of ,1100–2200 copies between 8.5
dpc and 14.5 dpc. The drastic reduction in PGC mtDNA content
at 7.5 dpc was suggested to be the cause of the bottleneck [13].
Taking advantage of using Oct4DPE-EGFP mice heteroplasmic for
two mtDNA sequence variants, Wai et al. [14] measured both
mtDNA copy number and heteroplasmy in single germ cells. They
detected that PGCs possessed a mean of ,280 mtDNA copies
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could be isolated in their mouse strain, and a mean of ,2000–
6000 copies per germ cell between 9.5 dpc and 16.5 dpc.
Interestingly, despite the remarkable low mtDNA content in 8.5
dpc PGCs, an increase in genotypic variance at any point during
embryonic oogenesis was not found. Instead an inequality of
genotypic variance in germ cells between postnatal day 8 and day
11 was discovered. It was concluded that the mitochondrial
genetic bottleneck occurs not during embryonic oogenesis but
during postnatal oocyte maturation through replicating a subpop-
ulation of genomes [14]. The two reports by Cao et al. [12] and
Wai et al. [14], therefore, reached concordant conclusions that the
genetic bottleneck is not attributed to the decline in PGC mtDNA
content. However, it remains unknown why three studies aimed to
determine mtDNA copy number in single PGCs produced distinct
results at early developmental stages, that is, while Cao et al. [12]
detected no severe decrease of mtDNA copies in PGCs, the other
two studies found a significant reduction in PGC mtDNA content
at 7.5 and 8.5 dpc, respectively [13,14]. One proposed explanation
is that the ALP histochemical staining used for PGC isolation may
confound mtDNA estimation made by qrt-PCR, while the PGC-
specific markers, Stella-GFP and Oct4DPE-EGFP, omit the staining
step and may interfere less with qrt-PCR amplification [13,14].
The other possible explanation is that the isolation of PGCs using
flow cytometry may introduce PGC sample contamination
[14,15]. Given the important implications of a mitochondrial
bottleneck in mtDNA disease inheritance, it is vital to determine
the true germline mtDNA copy number in order to fully
understand the underlying mechanisms of the bottleneck. In this
study we manually isolated PGCs from mice expressing fluorescent
proteins specifically in PGCs to by-pass ALP histochemistry and
flow cytometry sorting procedures, and examined mtDNA copy
number in single PGCs at different embryonic development stages.
The present results confirm that no severe reduction of mtDNA
content occurs in PGCs.
Results/Discussion
In this study we have focused on our reassessment of mtDNA
copy number in PGCs at 7.5 and 13.5 dpc. These two stages were
chosen because 7.5 dpc was the only stage showing significantly
different PGC mtDNA copies between the studies using either
ALP staining or PGC-specific reporter transgenic mice for PGC
identification, and the mean mtDNA copy numbers detected in
PGCs at other stages did not differ very much [12,13]. PGCs of
13.5 dpc would serve to compare the mtDNA copy numbers in
PGCs between the two developmental stages and between
genders. 7.5 and 13.5 dpc PGCs were isolated from mice
expressing: i) mRFP protein under the control of a Blimp1
genomic fragment [16]; and ii) GFP protein under the control of
an Oct4 genomic fragment with deletion of the proximal enhancer,
respectively [17,18]. Blimp1-mRFP and Oct4DPE-GFP are reliable
PGC markers at the corresponding developmental stages [18,19].
Our construct of Oct4DPE-GFP is identical to that in Yoshimizu
et al. [18].
Due to subtle variations in the time of conception, there is a
variation in the developmental stage of individual mouse embryos
at any given time point [20]. To examine whether PGC mtDNA
copy number differs among 7.5 dpc embryos of different
developmental stages we have identified and divided 7.5 dpc
embryos into two groups having morphology of early bud (EB)
stage and late bud (LB) stage, respectively.
Validation of Blimp1-mRFP as a reliable marker to identify
PGCs at EB and LB stages of 7.5 dpc embryos
Blimp1 expression marks nascent PGCs as well as precursors of
PGCs in early developing mouse embryos. In the restricted
posterior region (after removal of visceral endoderm) of 7.5 dpc
embryos, Blimp1 has been proved to express specifically in PGCs
[19]. To facilitate the isolation of PGCs without any staining steps
at 7.5 dpc, we used bacterial artificial chromosome (BAC)
transgenic mice in which monomeric red fluorescent protein gene
(mRFP) was inserted into the Blimp1 locus [16]. First we
determined the Blimp1-mRFP expression profile. At both EB
and LB stages mRFP expression was observed at the posterior end
of the embryonic ectoderm and visceral endoderm in embryos
(Figure 1B and 1J), consistent with the endogenous Blimp1
expression [19]. To further characterize Blimp1-mRFP positive
cells, embryos were immuostained for Stella (PGC7), a PGC-
specific marker, with the anti-Stella antibody whose specificity for
PGCs has been proved [21]. Stella was detected exclusively in
PGCs located at the posterior region of the embryos. All Stella
positive cells were Blimp1-mRFP positive. At EB and LB stages
Stella protein was expressed in 62.5% and 90% of Blimp1-mRFP
positive cells in the posterior region, respectively (embryo
number=2 at both stages) (Figure 2), which is comparable with
the results of Seki et al. [22]. As a second assay, we stained cells
isolated from the posterior fragments (visceral endoderm removed)
of Blimp1-mRFP embryos for alkaline phosphatase, another
classical marker of PGCs. Cells were divided into Blimp1-mRFP
positive and negative two groups prior to staining. At the EB stage,
Blimp1-mRFP positive and negative cells were 79.4% (n=34) and
0% (n=28) positive for ALP staining, while at the LB stage, 92.9%
(n=28) and 0% (n=40), respectively (Figure 3). The results agree
with that Blimp1 expression precedes that of Stella and alkaline
phosphatase [19]. The cells positive for Blimp1-mRFP but negative
for Stella are either precursors of PGC or PGCs with weak Stella
expression beyond the detection limit of anti-Stella antibody.
Taken together, the Blimp1-mRFP expression profile of our
Blimp1-mRFP line is highly similar to that of Blimp1 transgenic
Author Summary
Mutations of mtDNA are responsible for many types of
mitochondrial diseases in humans, including myopathy
and neurological disorders. Females carrying a mixture of
mutant and wild-type mtDNA variants transmit a variable
amount of mutant mtDNA to each offspring. The
proportion of mutated mtDNA inherited from the mother
determines the onset and severity of diseases. Studies
have suggested that the mtDNA genome is transmitted
through a bottleneck, but the underlying mechanism
remains controversial. By detecting mtDNA copy number
in single cells, we previously showed that the bottleneck
occurs without reduction of mtDNA content in germline
cells. However, recently a study reported a marked decline
of mtDNA copies in embryonic germ cells and attributed
this reduction to the creation of the bottleneck. Yet
another study concluded that the bottleneck occurs
during postnatal oocyte maturation and not during
embryonic oogenesis. To resolve these controversies, we
examined mtDNA copies in embryonic germ cells identi-
fied using the same methodology as in the other two
studies. We show solid evidence to confirm our previous
findings. This confirmation is important because the
understanding of mtDNA content in female germ cells
will facilitate the development of therapeutic strategies
preventing the transmission of mitochondrial diseases
from mother to offspring.
Mitochondrial Bottleneck without mtDNA Reduction
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as a reliable marker to identify PGCs in the posterior region of the
embryo at EB and LB stages.
Moderate copy number (mean .1,000) of mtDNA in
PGCs and low copy number of mtDNA in embryonic
somatic cells
The mean numbers of mtDNA molecules in single 7.5 dpc EB
and LB, 13.5 dpc female and 13.5 dpc male PGCs were 1396,
1479, 1747 and 2039, respectively. Of note, no extremely low
mtDNA copy number was detected in any PGCs, and the
minimum number of mtDNA copies determined in single PGCs
was 767. The variation in mtDNA copy number per cell was
similar for each group of PGCs (CV=0.25–0.45, Table 1,
Figure 4). At 13.5 dpc no significant difference in the average
mtDNA copy number between female and male PGCs was
observed (t-test, P=0. 06). In contrast, somatic cells from the
gonad were found to contain less than half the number of mtDNA
copies found in PGCs at 13.5 dpc (mean mtDNA copy number in
somatic cells=702) (Table 1, Figure 4). All these results are,
therefore, in very good agreement with previous estimates
obtained from PGCs identified by alkaline phosphatase activity
[12], taking into account that the cell samples in the present study
were collected randomly without cell size classification. The
present data confirm our previous findings [12]: i) There is no
occurrence of remarkable reduction of mtDNA copies in early
PGCs; ii) The amount of mtDNA molecules in PGCs is moderate
(mean .1000 copies, comparable with that in adult somatic cells
[23]) and consistent across stages; and iii) Embryonic somatic cells
possess much lower mtDNA amount than PGCs.
How can we explain the discrepant findings among Cree et al.
[13], Wai et al. [14] and ours? Cree et al. [13] detected median
,200 mtDNA copies (mean 451) in PGCs at 7.5 dpc and more
than 1000 copies at later stages. This result may be associated with
the aspects of their methodology for PGC sorting. Cree et al. [13]
identified and sorted PGCs by flow cytometry. Isolation of PGCs
using flow cytometry was shown to be inaccurate for early
developmental stage embryos [14,15]. Szabo et al. [15] carried out
PGC sorting from Oct4DPE-EGFP transgenic mice that were
generated using the construct identical to that in Yoshimizu et al.
[18]. This Oct4DPE-EGFP were reported to be specifically
expressed in PGCs from 8.5 dpc onwards [17,18]. At 8.5 dpc
(five somites) only 62% EGFP
+ cells sorted by flow cytometry were
positive for the PGC marker, whereas 96% or more were positive
at 9.5 dpc and later stages [15], indicating the inaccuracy of flow
cytometry in identifying GFP cells expressing a PGC marker at
early developmental stages when PGCs are small in number
relative to non-PGC cells in the sample. The number of PGCs in
single embryos at 7.5 dpc is even smaller than at 8.5 dpc.
Figure 1. Isolation of single PGCs from 7.5 dpc early bud (A–H) and late bud (I–N) stage Blimp1-mRFP embryos. (A,C,E,G,I,K,M) Light
microscopy images. (B,D,F,H,J,L,N) Fluorescent microscopy images. At both EB and LB stages mRFP was detected as a cluster in the posterior part of
the embryo (dashed rectangle) and in the visceral endoderm (arrowheads). For isolating PGCs, the posterior regions bearing PGCs were cut off
carefully to remove the visceral endoderm (E,F,K,L). The resulting tissue fragments were disaggregated through trypsinization, and single PGCs with
fluorescence were collected unambiguously using micromanipulators under a fluorescent microscope (G,H,M,N).
doi:10.1371/journal.pgen.1000756.g001
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PLoS Genetics | www.plosgenetics.org 3 December 2009 | Volume 5 | Issue 12 | e1000756Figure 3. Alkaline phosphatase staining pattern of cells from the posterior region of Blimp1-mRFP embryos. (A,B) Cells from EB stage.
(C,D) Cells from LB stage. (A,C) Blimp1-mRFP negative cells. (B,D) Blimp1-mRFP positive cells. Scale bar, 20 mm.
doi:10.1371/journal.pgen.1000756.g003
Figure 2. Stella expression in the posterior region of Blimp1-mRFP transgenic mouse embryos. Blimp1-mRFP (red, left column), Stella
(green, middle column), and overlapped images (right column) at the EB (top row) and LB (bottom row) stages.
doi:10.1371/journal.pgen.1000756.g002
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+ cells sorted
and analyzed by Cree et al. [13] at 7.5 dpc were not PGCs but
somatic cells. Embryonic somatic cells have been shown to contain
significantly lower amounts of mtDNA than PGCs [12,24]. By
studying whole embryos, Aiken et al. [24] reported that the mean
of mtDNA copies per somatic cell was ,300 between 6.5 dpc and
Figure 4. mtDNA copy number in single cells of 7.5 and 13.5 dpc mouse embryos (logarithmic scale). Open black circles, primordial
germ cells (PGCs); Open grey circles, somatic cells. Each circle represents a single cell. Horizontal lines indicate mean values. EB, early bud stage. LB,
late bud stage. F, M, and Soma denote samples from female PGCs, male PGCs, and gonadal somatic cells, respectively.
doi:10.1371/journal.pgen.1000756.g004
Table 1. mtDNA copy number in single cells of early developing mouse embryos.
Stage Sorting marker Gender Cell size n
Mean mtDNA copy
number (610
2)
Median mtDNA copy
number (610
2) Range (610
2)C V
Primordial germ cells
7.5 dpc ALP staining (+)L
a 19 23.16 21.54 16.88–33.35 0.23
ALP staining (+)M
a 19 20.01 18.37 12.44–31.18 0.29
ALP staining (+)S
a 15 17.30 16.36 12.58–31.43 0.26
EB Blimp1-mRFP (+) 25 13.96 13.34 7.67–23.27 0.25
LB Blimp1-mRFP (+) 83 14.79 13.86 8.18–40.75 0.35
13.5 dpc ALP staining (+) Female L
a 15 36.56 27.49 18.78–94.50 0.65
ALP staining (+) Female M
a 25 18.43 18.16 11.44–32.04 0.25
ALP staining (+) Female S
a 31 15.32 14.04 9.95–32.35 0.32
Oct4DPE-GFP (+) Female 35 17.47 17.03 9.23–55.98 0.45
ALP staining (+) Male L
a 16 30.53 27.61 12.9–87.28 0.56
ALP staining (+) Male M
a 28 18.95 19.60 3.78–34.52 0.33
ALP staining (+) Male S
a 26 13.50 12.88 3.26–25.06 0.37
Oct4DPE-GFP (+) Male 65 20.39 19.68 11.90–40.79 0.29
Somatic cells
13.5 dpc ALP staining (2) Female L
a 10 6.45 6.07 3.44–8.90 0.25
ALP staining (2) Female S
a 9 4.86 4.50 0.39–9.55 0.63
Oct4DPE-GFP (2) Female 35 7.02 6.54 0.74–16.29 0.58
Range, range in mtDNA copy number of cells. CV, coefficient of variation in mtDNA copy. EB, early bud stage. LB, late bud stage. number. (+) and (2) stand for positive
and negative, respectively.
a Data are from Cao et al. [12]. L, large size cell. M, medium size cell. S, small size cell. Somatic cells are from 13.5 dpc female gonads.
doi:10.1371/journal.pgen.1000756.t001
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sample of Cree et al. [13]. In contrast, our isolation of 7.5 dpc
PGCs was performed manually under a fluorescent microscope
using micromanipulators. Hence the purity of PGCs was ensured
(Figure 1). Wai et al. [14] found a median of 145 mtDNA copies
(mean ,280) per PGC at 8.5 dpc and more than 1000 copies at
other stages. It is currently unclear why the study of Wai et al. [14]
gave the result significantly different from that of Cree et al. [13]
and ours for 8.5 dpc PGCs. However, the fact that both Cree et al.
[13] and Cao et al. [12] detected a mean of mtDNA copies more
than 1000 per 8.5 dpc PGC weakens the possibility of extremely
lower mtDNA copy number (mean ,280) in 8.5 dpc PGCs.
Why do PGCs contain more than 1000 mtDNA copies in sharp
contrast with consistent ,300 per embryonic somatic cell across
stages between 6.5 dpc and 18.5 dpc? One explanation is that the
moderate mtDNA copy number in PGCs allows the cell to have an
elevated tolerance for less deleterious mtDNA mutations and
serves as a device to maintain the adaptive potential of mtDNA
genome, which for a nuclear genome is achieved via diploidy by
means of sexual reproduction. On the other hand, a tight physical
bottleneck in somatic lineages during embryonic development
enables pathogenic mtDNA mutations (both severe and less
deleterious variants) to rapidly segregate and be eliminated more
efficiently. The mtDNA copy number in gonadal somatic cells at
13.5 dpc was much higher (mean 702) than the average mtDNA
level per cell of the whole embryo (mean ,300) [24], suggesting
that the physical bottleneck in embryonic somatic cells appears
lineage specific which might be associated with tissue-specific cell
function and bioenergic demands. Alternatively, the moderate
mtDNA copy number may be entailed to meet the energetic
demand for PGC migration, mitotic replication and cell function.
Recent findings from two research groups have provided new
insight into the mtDNA segregation between generations. Wai
et al. [14] showed that the mtDNA genetic bottleneck occurs not
during embryonic oogenesis but during postnatal oocyte matura-
tion as a result of replication of a subgroup of mtDNAs. Fan et al.
[25] demonstrated a strong and rapid purification selection of
mtDNA in the germline, eliminating severe mutations within three
generations in mice. If the purifying filter takes effect only before
the cease of PGC proliferation by 13.5 dpc, females carrying
severe mtDNA mutations would produce progeny with a similar
frequency of mutant variants in any given litter. However the
female mice harbouring either ND6 frameshift mtDNA or
mtDNA with a 4696-bp deletion produced offspring with a
declining proportion of mutant mtDNA in their successive litters
[25,26], indicating that the purifying filter acts after 13.5 dpc. Data
from ND6 frameshift mtDNA mice have shown that the selection
appeared not to operate at embryonic stage through selectively
eliminating foetuses with the highest percentages of mutation [25].
One possibility is that the purifying selection acts at the cell level
through a competition between germ cells with different
proportions of severe mutant variants. When germ cells with the
highest ratio of severe mutations are held in the ovary for a long
time they might gradually lose their competence in competing to
develop into mature oocytes, as opposed to those with lower ratio
of mutations, due to the cumulative detrimental effect of mutation
on cells over time. Consequently the proportion of severe mutant
mtDNA would be lower in younger siblings and the severe
mutation would progressively be lost and eventually disappear in
following generations, which are the patterns revealed in the
mouse pedigrees harbouring either a ND6 frameshift mutation
[25] or a mtDNA large deletion mutation [26]. In human
pedigrees, a decline in the mtDNA mutation load in younger
siblings has not been found [27–30]. Pedigree studies of
pathogenic mutations in human mtDNA have mainly focused
on large deletion mutations and point mutations (either missense
mutations in protein genes or base substitution mutations in tRNA
and rRNA genes). These point mutations are apparently milder
than the ND6 frameshift mutation resulting in a premature
termination of gene transcription [25] and the mtDNA large
deletion mutation where a number of genes were missing from the
genome [26], and hence, may not undergo a strong purification
selection in the germline. Deletion mtDNAs in humans were
suggested not to be maternally transmitted, rather to arise
spontaneously, since mothers and siblings of affected individuals
rarely harboured deletion mtDNAs [31]. It is possible that the
purification selection of germline mtDNA is much stronger in
humans than in mice, and virtually no large deletion mtDNAs in
human oocytes would survive this selection. In rare cases where a
deleted genome slips through, clonal expansion of such a deleted
molecule(s) in embryogenesis could lead to mitochondrial disease
in the child. Taken together, these may explain the failure to find a
decrease in mtDNA mutation load in offspring as maternal age
increases in human pedigrees. Alternatively, severe mtDNA
mutations could be selected against at the organelle level [32].
Mitochondria with a higher proportion of mutation diminish with
time, leading to a decline of mutant mtDNA in oocytes. The
selection at the organelle level could be oocyte-specific, since it is
not supported by measurements of deletion mutation loads in non-
dividing somatic tissues in which mutant mtDNAs accumulate
with age [33,34]. It is known that the number of mtDNA copies
per mitochondrion decreases during oogenesis, and eventually
reaches approximately a mtDNA per mitochondrion in mature
oocytes [35]. This decline of mtDNA copy number in single
mitochondria may render the mitochondrion more sensitive to
severe mutations and facilitate the elimination of mutant
mitochondria in oocytes.
In summary, our new data show solid evidence that there is no
drastic reduction of mtDNA copy number in PGCs. The amount
of mtDNA in single PGCs is moderate and comparable at 7.5 and
13.5 dpc stages, while somatic cells in 13.5 dpc gonads contain far
fewer mtDNA copies than PGCs. The results from this and our
previous study [12] are highly consistent despite using different
mouse lines (wild-type mice vs. transgenic mice) and different PGC
isolation methods. These results reinforce our conclusion that the
mitochondrial bottleneck occurs without reduction of mtDNA
copy number in germline cells, which is also supported by the
study showing the mtDNA genetic bottleneck occurrence as a
result of replication of a subpopulation of mtDNA genome and not
a remarkable reduction in PGC mtDNA content [14]. The rapid
segregation of mtDNA variants between generations is likely
achieved through a genetic bottleneck resulting from replication of
a subgroup of mitochondrial genome during oocyte maturation
[14] in combination with a strong purifying selection against
severe mutations over a long time period in the germ line [25].
The reconfirmation of mtDNA copy numbers in PGCs in the
present study is of importance because it clarifies the confusions
and the information of germline mtDNA content will facilitate the
development of therapeutic strategies blocking the mitochondrial
disease transmission from mother to progeny.
Materials and Methods
Transgenic mouse strains
Blimp1-mRFP transgenic mice (BDF1 background) were
generated using a 203-kb bacterial artificial chromosome (BAC)
expressing mRFP under the control of Blimp1 regulatory elements
as previously described [16]. Oct4DPE-GFP mice (BDF1 back-
Mitochondrial Bottleneck without mtDNA Reduction
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Yoshimizu et al.’s [18], carrying the GFP sequence driven by an
18-kb Oct4 genomic fragment with deletion of the proximal
enhancer [16].
The Blimp1-mRFP mouse strain (RBRC01830) and Oct4DPE-
GFP mouse strain (RBRC00821) were provided by the RIKEN
BioResource Center (http://www.brc.riken.jp/inf/en/). All ani-
mal experiments were approved by the Institutional Animal
Experiment Committee of RIKEN BioResource Center and of the
Tokyo Metropolitan Institute of Medical Science.
Immunostaining analyses
7.5 days post coitum (dpc) embryos of Blimp1-mRFP mice were
collected in Dulbecco’s Modified Eagle’s Medium (DMEM)
(Invitrogen) supplemented with 10% FCS, and were further
precisely classified as at either early bud (EB) or late bud (LB) stage
according to the morphological landmarks [20]. Immunohisto-
chemistry assay was carried out as in Sugimoto and Abe [16].
Briefly, isolated embryos were incubated in PBS containing 0.5%
Triton X-100 for 3–5 min on ice and fixed with 4% paraformal-
dehyde in PBS for 10 min at room temperature. Following
stringent washing, the embryos were incubated with anti-Stella
primary antibody (1:1,000) (kindly provided by Dr. Toru Nakano)
diluted with blocking buffer (PBS containing 1% BSA and 0.1%
Triton X-100) for 1 h at room temperature, washed with washing
buffer (PBS in 0.1% Triton X-100), and incubated with Alexa-
Fluor-488 conjugated goat-anti-rabbit secondary antibody diluted
in blocking buffer for 45 min at room temperature. Fluorescent
images were acquired in Z series every 0.82 mm using Zeiss
LSM510 Meta confocual microscope.
Posterior fragments after removal of visceral endoderm from
Blimp1-mRFP embryos of EB and LB stages were dissected out.
The fragments were disaggregated with Trypsin. Cells were
divided into Blimp1-mRFP negative and positive groups, and
underwent alkaline phosphatase (ALP) staining as in Cao et al.
[12].
Isolation of single PGCs and single somatic cells
(C57BL/6N6DBA/2N)F1 female mice were mated with
Blimp1-mRFP and Oct4DPE-GFP males. 7.5 and 13.5 dpc embryos
were collected in DMEM supplemented with 10% FCS. The
restricted posterior parts of 7.5 dpc EB and LB Blimp1-mRFP
embryos bearing PGCs (visceral endoderm removed, Figure 1) and
the gonads of 13.5 dpc Oct4DPE-GFP embryos were isolated using
fine needles, and incubated in Trypsin-EDTA solution (Sigma) at
37uC for 10 min. Cells were dissociated in DMEM supplemented
with 10% FCS by pipetting, were pelleted and washed twice in
PBS and were resuspended in modified Dulbecco’s phosphate-
buffered medium (PBI). Single PGCs expressing fluorescent
proteins and the gonad somatic cells were randomly collected
under a fluorescent microscope using micromanipulators (Leica).
PGCs from female and male gonads were isolated separately at
13.5 dpc, at which time the gender of the fetus can be identified
microscopically.
Estimation of mtDNA copy number by quantitative real-
time PCR (qrt–PCR)
Single cells were extracted and used directly for qrt-PCR
analysis as previously described [12,36]. Quantification of absolute
mtDNA copy number per cell was carried out by the standard
curve method. Details of the probe, primers and standard DNA
are as in Cao et al. [12]. To evaluate whether pure DNA of
plasmids containing mouse mtDNA fragment is suitable to serve as
standard DNA for the measurement of mtDNA copy number in
single cells, we performed qrt-PCR on samples containing the
plasmid DNA in the presence of a single mtDNA-less r
0B82 cell
using pure plasmid DNA as standard DNA as described previously
[12], and compared the sample plasmid copy numbers estimated
by PCR with their corresponding true copy numbers. r
0B82 line
was derived from L cells [37,38] whose mtDNAs encompass the
same mtDNA fragment integrated into the plasmid. Mixing the
plasmid DNA with a r
0B82 cell creates sample conditions closer to
that of single cell DNA for PCR amplification. It showed that the
estimated copy values highly correlated with their true copy values
(r
2.0.99) over a range of mtDNA concentrations that comprise
the values detected in our single cell studies (Figure S1), indicating
that a systematic underestimation or overestimation of actual
plasmid copies did not occur. Therefore the pure plasmid DNA is
suitable for using as standard DNA for our determination of
mtDNA copies in single cells. This qrt-PCR system could detect as
few as 10 copies of standard DNA template reliably. The linear
regression analysis of all standard curves for samples with copy
numbers between 10 and 10
6 showed a high correlation (r
2.0.99).
Samples from both 7.5 and 13.5 dpc were measured in at least
duplicate plates to avoid systematic errors that may be caused by
transfer of standard DNA or other factors. The means of mtDNA
copy number determined from the plates were assessed by t-test.
No significant differences were found between the plates carrying
the samples of matched categories.
Supporting Information
Figure S1 Correlation between plasmid copy values measured
by qrt-PCR and their corresponding true copy values in samples
containing plasmid DNA in the presence of a r
0B82 cell. Plasmid
DNA was quantified and serially diluted. Each dilution was added
with a single r
0B82 cell and underwent qrt-PCR amplification in
triplicate using PCR conditions referred to in the manuscript text.
The graphs represent the results of two independent assays. A tight
correlation between the measured copy number values and their
true copy number values was found in both assays (R
2.0.99).
Found at: doi:10.1371/journal.pgen.1000756.s001 (8.43 MB TIF)
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